Katsumi Yamamoto
Josai University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Katsumi Yamamoto.
Archives of Pharmacal Research | 1999
Katsuya Sakuma; Masayuki Ogawa; Kenji Sugibayashi; Koh-ichi Yamada; Katsumi Yamamoto
The oxidation-reduction potentials of cosmetic raw materials, showing tyrosinase inhibitory action, and phenolic compounds structurally similar to L-tyrosine were determined by cyclic voltammetry. The voltammograms obtained could be classified into 4 patterns (patterns 1–4). Pattern 1, characterized by oxidation and reduction peaks as a pair, was observed with catechol, hydroquinone or phenol, and pattern 2 exhibiting another oxidation peak in addition to oxidation and reduction peaks as a pair was found with arbutin, kojic acid, resorcinol, methyl p-hydroxybenzoate and L-tyrosine as the substrate of tyrosinase. Pattern 3 with an independent oxidation peak only was expressed by L-ascorbic acid, and pattern 4 with a reduction peak only at high potentials, by hinokitiol. The tyrosinase inhibitory activity of these compounds was also evaluated using the 50% inhibitory concentration (IC50) and the inhibition constant (Ki) as parameters. Hinokitiol, classified as pattern 4, showed the highest inhibitory activity (lowest IC50 and Ki). Hydroquinone showing the second highest activity belonged to pattern 1, which also included compounds showing no inhibition of tyrosinase activity. The inhibitory activity of compounds exhibiting pattern 2 was relatively low with Ki values being in the order of 10−4 M. Although there was no consistent relationship between oxidation-reduction potentials and tyrosinase inhibitory action, the voltammetry data can be used as an additional index to establish the relationship between the structure and the tyrosine inhibitory activity.
Tetrahedron Letters | 1999
Masami Kawase; Michitaka Hirabayashi; Setsuo Saito; Katsumi Yamamoto
Abstract Trifluoromethyl-substituted heterocycles have been prepared by condensation of the new 4-trifluoroacetyl-2,3-dihydropyrroles with hydrazines or amidines as a bifunctional N-nucleophile with opening of the dihydropyrrole ring.
Bioscience, Biotechnology, and Biochemistry | 2006
Masayuki Ogawa; Jyunichi Koyanagi; Aiko Sugaya; Tadashi Tsuda; Hiromi Ohguchi; Kouji Nakayama; Katsumi Yamamoto; Akira Tanaka
We investigated the cytotoxic activity of 2-substituted naphtho[2,3-b]furan-4,9-diones. We have previously synthesized 33 types of 2-substituted and related compounds, and the cytotoxic activity of these compounds was then examined by a KB cell culture assay. 2-(3-Furanoyl)benzoic acids and 1,4-naphthoquinones had no activity. 2-Acetyl-4,9-dimethoxynaphtho[2,3-b]furan 4 showed low activity. However, parent naphtho[2,3-b]furan-4,9-dione 2 and most 2-substituted derivatives exhibited cytotoxic activity. The parent structure was therefore for cytotoxicity. 2-Formylnaphtho[2,3-b]furan-4,9-dione 11 had particularly potent activity (ED50=0.09 μg/ml).
Chemical Communications | 1998
Masami Kawase; Michitaka Hirabayashi; Hiromi Koiwai; Katsumi Yamamoto; Hiroshi Miyamae
A novel transformation of N-alkoxycarbonylprolines 1 to 4-trifluoroacetyl-2,3-dihydropyrroles 2 was efficiently realized by utilizing trifluoroacetic anhydride, in which probable intermediates were mesoionic 1,3-oxazolium-5-olates B.
Archives of Pharmacal Research | 1996
Katsuya Sakuma; Izumi Kaji; Masahiko Ogihara; Katsumi Yamamoto
We examined the effect of topical application of Shimotsu-to, a traditional Chinese herbal prescription, on carrageenin-induced edema in rats and ultraviolet radiation-induced erythema in guinea pigs. Shimotsu-to (5% in water) markedly suppressed an acute edema of rat hindpaw induced by 1% carrageenin, and was more effective than any other single crude drug componcent of Shimotsu-to, Topical treatment with this prescription also inhibited ultraviolet erythema on the back skin of guinea pigs (a human sunbrun model). These results suggest the therapeutic effect on acute inflammation by topical application of Shimotsu-to.
Anticancer Research | 2009
Ayako Takano; Ken Hashimoto; Masayuki Ogawa; Jyunichi Koyanagi; Teruo Kurihara; Hidetsugu Wakabayashi; Hirotaka Kikuchi; Yukio Nakamura; Noboru Motohashi; Hiroshi Sakagami; Katsumi Yamamoto; Akira Tanaka
Journal of Heterocyclic Chemistry | 1997
Jyunichi Koyanagi; Katsumi Yamamoto; Kouji Nakayama; Akira Tanaka
Journal of Heterocyclic Chemistry | 1994
Jyunichi Koyanagi; Katsumi Yamamoto; Kouji Nakayama; Akira Tanaka
Carcinogenesis | 1986
Masataka Ichikawa; Katsumi Yamamoto; Akira Tanaka; Santhanam Swaminathan; James F. Hatcher; E. Ertürk; George T. Bryan
Chemical & Pharmaceutical Bulletin | 2000
Masami Kawase; Michitaka Hirabayashi; Hiroko Kumakura; Setsuo Saito; Katsumi Yamamoto